BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36097895)

  • 1. [Consensus on pathological diagnosis of ductal carcinoma in situ of breast (2022 version)].
    Members of Breast Cancer Expert Panel on Consensus on Pathological Diagnosis of Ductal Carcinoma In Situ of Breast (2022 version)
    Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):812-818. PubMed ID: 36097895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma.
    Hui Y; Lu S; Wang H; Resnick MB; Wang Y
    Histopathology; 2019 Jan; 74(2):358-362. PubMed ID: 30117181
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR is/is not a useful diagnostic tool for breast cancer management.
    Van Goethem M; Verslegers I; Biltjes I; Parizel PM
    Acta Chir Belg; 2007 Jun; 107(3):267-70. PubMed ID: 17685251
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on preoperative staging with breast MRI.
    Hollingsworth AB
    J Am Coll Surg; 2004 Jul; 199(1):173-4. PubMed ID: 15217651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].
    Sinn HP; Flechtenmacher C; Aulmann S
    Pathologe; 2014 Feb; 35(1):18-25. PubMed ID: 24448666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCIS (Ductal carcinoma in situ)-like invasive ductal carcinoma of the breast.
    Zhao H; Ming X; Yang Z
    Asian J Surg; 2022 Oct; 45(10):1855-1856. PubMed ID: 35410836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
    Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
    BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breast neoplasms: histological classification].
    Sakamoto G
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():54-9. PubMed ID: 17682139
    [No Abstract]   [Full Text] [Related]  

  • 12. Cystic Presentation of High-Grade Ductal Carcinoma In Situ in an Inframammary Accessory Nipple.
    Lee C; Hedayat AA; Greenberg HL
    Cutis; 2023 Aug; 112(2):E9-E11. PubMed ID: 37820342
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical ductal hyperplasia from stereotactic core biopsy of the breast.
    Montgomery S
    AJR Am J Roentgenol; 1996 May; 166(5):1230. PubMed ID: 8615279
    [No Abstract]   [Full Text] [Related]  

  • 14. Regressive change in high-grade ductal carcinoma in situ of the breast: histopathologic spectrum and biologic importance.
    Wasserman JK; Parra-Herran C
    Am J Clin Pathol; 2015 Sep; 144(3):503-10. PubMed ID: 26276781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis.
    Jatoi I
    J Clin Oncol; 2022 May; 40(14):1595. PubMed ID: 35245098
    [No Abstract]   [Full Text] [Related]  

  • 16. Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.
    Latronico A; Nicosia L; Faggian A; Abbate F; Penco S; Bozzini A; Cannataci C; Mazzarol G; Cassano E
    Breast; 2018 Feb; 37():1-5. PubMed ID: 29032282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Koss LG
    Diagn Cytopathol; 2005 Sep; 33(3):219. PubMed ID: 16078246
    [No Abstract]   [Full Text] [Related]  

  • 18. [In situ ductal carcinoma of the breast: a diagnostic challenge].
    Fuchsjäger MH; Helbich TH
    Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous Ductal Carcinoma In Situ and Intravascular Large B-cell Lymphoma of the Breast.
    Alakeel F; Lee E; Baird-Howell M; Easley S
    Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):e91-e92. PubMed ID: 28582274
    [No Abstract]   [Full Text] [Related]  

  • 20. Getting on the Nerves: A Case of Perineural Invasion by Mammary Ductal Carcinoma In Situ.
    Baum J; Magpayo J; Hoda S
    Int J Surg Pathol; 2019 Sep; 27(6):647-648. PubMed ID: 30482072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.